Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Synopsys funds relentless R&D, books multi-year license revenue, or discloses its latest IP acquisition can feel like decoding a 300-page textbook. That complexity is why questions such as “Synopsys SEC filings explained simply” or “Synopsys insider trading Form 4 transactions” appear so often in search boxes.
Stock Titan solves the puzzle. Our platform delivers AI-powered summaries that turn every Synopsys annual report 10-K simplified, each Synopsys quarterly earnings report 10-Q filing, and even the briefest Synopsys 8-K material events explained into clear narrative. Need real-time alerts? Synopsys Form 4 insider transactions real-time show exactly when executives exercise options, while the dashboard links directly to Synopsys executive stock transactions Form 4 for deeper context. You’ll also find side-by-side Synopsys proxy statement executive compensation tables and concise Synopsys earnings report filing analysis, all updated the moment EDGAR releases.
The result: faster insight into how EDA tools, semiconductor IP, and software-security services shape revenue streams; instant visibility on share repurchases or option grants; and confidence when comparing backlog trends quarter-over-quarter. Whether you’re monitoring dilution risk, studying segment margins, or simply understanding Synopsys SEC documents with AI, every filing type—10-K, 10-Q, 8-K, S-8, or Form 4—is ready when you are, explained in language that empowers decisive action.
Synopsys, Inc. files its annual report for the fiscal year ended October 31, 2025, outlining a business built around two segments: Design Automation and Design IP. The company positions itself as a leader in engineering solutions "from silicon to systems," with core strength in electronic design automation (EDA), silicon IP and simulation and analysis (S&A) software.
A key development is the acquisition of ANSYS, Inc., which adds a broad portfolio of multiphysics S&A tools to the Design Automation segment and helped increase total headcount by about 40% to roughly 28,000 employees. Synopsys now reports four revenue groups: EDA, Design IP, Ansys and Other, and highlights growing use of AI-driven tools through its Synopsys.ai stack across design, verification and manufacturing.
The report notes an aggregate market value of about $59.3 billion for non‑affiliate common equity as of the last business day of the most recent second fiscal quarter, and 191,318,206 common shares outstanding as of December 15, 2025. Synopsys also describes a new October 31 fiscal year-end, a global footprint of 189 offices, and emphasizes responsible business, human capital investment, and extensive use of forward‑looking statements around AI, the Ansys Merger, macroeconomic conditions and regulatory risks.
Synopsys Inc. reported an equity award for its Chief Financial Officer, Shelagh Glaser. The Compensation Committee granted her 7,554 restricted stock units under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. These units have a conversion price of $0.0 and represent potential shares of common stock.
One-sixth of the units vest on 12/16/2025, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, contingent on continued service. Following the grant, she holds 7,554 derivative securities directly.
Synopsys, Inc. reported an equity award for its Chief Accounting Officer, Sudhindra Kankanwadi. On 12/16/2025, he received a grant of 4,317 restricted stock units (RSUs) under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. Each RSU represents a right to receive one share of Synopsys common stock for no cash exercise price.
According to the vesting schedule, one-sixth of the units vest on 06/15/2026, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, as long as he continues to provide service to the company through each vesting date. This filing reflects a routine compensation-related grant rather than a market sale or purchase of shares.
Synopsys Inc reported an equity award to its Executive Chair and director, Aart de Geus. On 12/16/2025, he received 2,693 restricted stock units classified as derivative securities with an exercise price of $0.0, beneficially owned directly.
The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on 06/15/2026, followed by five equal semi-annual installments, conditioned on continued service through each vesting date. The RSUs are scheduled to expire on 12/15/2028.
Synopsys, Inc. reported an equity award to one of its senior executives. On 12/16/2025, officer Janet Lee, who serves as GC & Corporate Secretary, received a grant of 3,238 restricted stock units under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. Each unit represents a right to receive one share of Synopsys common stock for no cash exercise price.
According to the vesting terms, one-sixth of the units vest on 06/15/2026, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, subject to continued service. The award is reported as directly owned and is a routine part of executive equity compensation, not an open-market stock sale or purchase.
Synopsys, Inc. reported that Chief Revenue Officer Michael Ellow received a grant of 24,286 restricted stock units on December 12, 2025. Each unit represents the right to receive one share of Synopsys common stock for no cash payment.
The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on June 15, 2026, with the remaining units vesting in five equal semi-annual installments through December 15, 2028, subject to Mr. Ellow’s continued service.
Synopsys, Inc. (SNPS) filed an initial ownership report for its Chief Revenue Officer. The filing states that, as of the event date of 11/20/2025, the reporting officer does not beneficially own any Synopsys securities, either non-derivative or derivative. The form is filed by one reporting person and confirms their executive role and current lack of reportable equity holdings in the company.
Synopsys (SNPS) announced a restructuring plan tied to its ANSYS integration, calling for the termination of approximately 10% of its workforce as of fiscal 2025 year-end. The company expects to recognize pre-tax GAAP charges of $300 million to $350 million for severance, one-time termination benefits, and costs such as certain site closures under its global site strategy.
Synopsys plans for a majority of the workforce reductions in fiscal year 2026 and aims to substantially complete the plan by the end of fiscal year 2027, subject to local law and consultation requirements. Management frames the move as a way to invest in key growth opportunities and drive efficiencies following the ANSYS acquisition. Forward-looking statements note potential changes in the scope, timing, and cost of the actions.
Synopsys, Inc. announced that Chief Revenue Officer Rick Mahoney will no longer serve in the role, effective immediately. The company said it is in advanced stages of its search and expects to announce a replacement shortly.
Synopsys reaffirmed its financial targets for the fourth quarter and full fiscal year 2025 and plans to discuss results on its earnings call on December 10, 2025. The update was provided under Item 7.01 and is not deemed filed under the Exchange Act.
Sudhindra Kankanwadi, Chief Accounting Officer of Synopsys, reported option exercises and share sales in two transactions on September 19 and September 22, 2025. On September 19 he exercised 6,000 non-qualified stock options with an exercise price of $89.76 and sold 6,000 shares (sale price listed as $482). On September 22 he exercised 9,873 options at $89.76 and sold 9,873 shares at a weighted average reported sale price in the filing of $500.90 to $501.04. Following these reported transactions the filing shows he beneficially owns 20,520 shares of Synopsys common stock. The form was signed by POA Liz Ramirez for Mr. Kankanwadi on September 23, 2025.
FAQ
What is the current stock price of Synopsys (SNPS)?
What is the market cap of Synopsys (SNPS)?
